-
As a women's health care provider, you are familiar with interstitial cystitis (IC) and painful bladder syndrome (PBS). It is estimated that at least 1 million Americans suffer from IC/PBS, most of them women.
-
If your clinical practice includes treatment of perimenopausal women, the subject of hot flashes is familiar territory for you. In a 2002 national survey of menopausal women, hot flashes (70%) led the top four reasons for seeking medical attention, followed by night sweats (68%), mood disturbances (50%), and sleep disturbances (49%).
-
Recent research findings indicate that young women who use the commonly used epilepsy drug phenytoin for one year showed significant bone loss compared to women taking other epilepsy drugs.
-
The woman in your exam room says she is experiencing a painful, burning sensation when urinating, and reports increased vaginal discharge. The test is positive for gonorrhea. What's your next move?
-
The teenager in front of you says she has some bumps on her genital area. A closer inspection shows several flesh-colored, flat growths on her vulva. What's your next move?
-
Your last patient has left the exam room with a prescription for birth control in her hand. You counseled on proper use and covered the expected side effects. Is she now protected against unintended pregnancy?
-
Pioglitazone and heart disease; ARBs manufacturers spend millions to show the non-inferiority of their products compared to less expensive, generic ACE inhibitors; some athletes turn to growth hormone because it is difficult to detect; FDA Actions
-
-
Most of us dread the chief complaint of weakness. This nonspecific symptom engenders a differential that ranges from malingering to fatal, from psychiatric to cancer. The finding of demonstrable muscle weakness helps, but then leads to a confusing set of relatively rare diagnoses.
-
Another monoclonal antibody to TNF-a has been approved for the treatment of Crohn's Disease.